(Q54597928)

English

LAEVADOSIN IN TREATMENT OF DUCHENNE TYPE OF MUSCULAR DYSTROPHY: PRELIMINARY RESULTS OF A DOUBLE-BLIND CONTROLLED TRIAL.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

LAEVADOSIN IN TREATMENT OF DUCHENNE TYPE OF MUSCULAR DYSTROPHY: PRELIMINARY RESULTS OF A DOUBLE-BLIND CONTROLLED TRIAL. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

muscular dystrophy

1 reference

based on heuristic

inferred from title

author name string

PEARCE JM

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

GUBBAY SS

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

HARDY J

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

PENNINGTON RJ

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

NEWELL DJ

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

WALTON JN

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

language of work or name

0 references

publication date

1 October 1964

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

number of pages

3

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

915-917

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

5414

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

A trial of therapy by nucleosides and nucleotides in muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1816923

4 June 2018

[The use of methylandrostendiol(neosteron) in the treatment of progressive muscular dystrophy.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/14185658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[On the treatment of muscular diseases by anabolic steroids. I. Metabolic studies.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/14185658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methandrostenolone and nandrolone decanoate in muscular dystrophy; a controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14185658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TREATMENT OF MUSCULAR DYSTROPHY WITH A NUCLEOTIDES- NUCLEOSIDES COMBINATION

1 reference

https://pubmed.ncbi.nlm.nih.gov/14185658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The effects of anabolizing steroids on creatine metabolism in progressive muscular dystrophy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/14185658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.2.5414.915

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/PMC/1816923

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54597928&oldid=1901618009"